Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was
Today 14:46(Alliance News) - GlaxoSmithKline on Monday said a study of ovarian cancer treatment Zejula met its primary endpoint of a statistically significant improvement in progression free survival for of
15 Jul 19 08:43(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK news,
15 Jul 19 07:40(Sharecast News) - GlaxoSmithKline announced positive results from its 'PRIMA' phase 3 randomised, double-blind, placebo-controlled study of 'Zejula' (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy on Monday.
15 Jul 19 07:25(Alliance News) - GlaxoSmithKline PLC on Wednesday noted that the Tango study of a dolutegravir plus lamivudine two-drug regimen in HIV-1 met its primary endpoint.The phase 3 Tango study a
10 Jul 19 07:57(Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare has commenced a trial to identify and evaluate approaches to implementing a once-monthly, injectable treatment for HIV into is
8 Jul 19 13:53(Sharecast News) - Computacenter: Barclays upgrades to equal weight with a target price of 1,260p.
8 Jul 19 13:18(Alliance News) - GlaxoSmithKline PLC on Wednesday announced the European Commission has given marketing authorisation to HIV-1 drug Dovato.Dovato, a two-drug regimen of dolutegravir and by
3 Jul 19 09:41(Sharecast News) - GlaxoSmithKline's investee company, ViiV Healthcare, has received European Commission marketing authorisation for Dovato, which treats HIV-1 in adults and adolescents.
3 Jul 19 09:30(Sharecast News) - GlaxoSmithKline (GSK) confirmed on Monday Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for its Zejula cancer treatment.
24 Jun 19 13:18(Alliance News) - GlaxoSmithKline PLC on Monday said Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for drugmaker the
24 Jun 19 12:25(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.
17 Jun 19 12:21(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday.
12 Jun 19 12:34LONDON (Alliance News) - Stock prices in London are set to open higher Friday after a disappointing finish Thursday as the European Central Bank failed to boost sentiment.In London, FTSE Smiths a
7 Jun 19 07:36(Sharecast News) - GlaxoSmithKline said on Friday that US regulators had approved two new methods for self-administering its Nucala asthma treatment.
7 Jun 19 07:15
Last checked at